Latest Earnings Growth News

Peak Processing has reported three consecutive months of positive EBITDA and raised its Q4 FY26 beverage production guidance to approximately 1.6 million units, surpassing earlier estimates.

Eureka Group Holdings (ASX: EGH) expects FY26 underlying EBITDA to meet or exceed $21.1 million, driven by seniors’ occupancy above 97% and rent growth exceeding 6%. Capital recycling and a robust acquisition pipeline support growth.

Aussie Broadband has finalized its takeover of AGL Telco, adding 350,000 connections and setting the stage for significant earnings growth. The company is also progressing key customer migrations and upgrading its growth ambitions toward 1.3 million NBN connections.

Ryman Healthcare nearly doubles operating profitability and generates positive free cash flow for the first time in over a decade, while shifting strategy toward sustainable growth and targeting dividend returns by FY28.

Evion Group’s Panthera Graphite Technologies joint venture posted a US$530,000 EBITDA in its first full year of commercial production, operating at just 20-25% capacity and setting the stage for substantial earnings growth.

Promisia Healthcare reported a 58% jump in underlying EBITDAF to $6.6 million for FY26, driven by improved occupancy and operational upgrades. The company introduced a dividend policy tied to operating free cash flow, signalling confidence in sustained cash generation.

SRG Global has locked in $1.85 billion in contracts across multiple sectors and upgraded its FY26 EBITDA guidance to the top end of $168 million, while initiating FY27 guidance between $190 million and $200 million, surpassing market expectations.

ArborGen Holdings delivered its strongest revenue in five years with $68.2 million, driven by a 14% surge in Brazil and an 8% rise in adjusted EBITDA despite US market headwinds. The company’s focus on advanced genetics and operational efficiency underpins a confident FY27 outlook.

Cuscal has finalised its purchase of New Zealand’s Paymark, aiming for earnings growth and a strong return on capital in the coming financial year.

Infragreen launches a strategic review revealing a $10 million on-market buyback and potential asset sales to address significant undervaluation despite strong FY26 growth forecasts.

Peet Limited has upgraded its FY26 net profit guidance by up to 17%, driven by accelerated construction and robust market demand in Western Australia and Queensland.

Australian Clinical Labs appoints Greg Horan as Group CEO effective August 2026, marking a leadership transition after a decade under Melinda McGrath. Horan’s healthcare and operational expertise positions ACL for its next growth phase.